'Having to deal with the mental and physical pains of cancer is bad enough, but it's worse when you have to fear the medicine used to treat it.

Hospira, the world's leading provider of injectable drugs and infusion technologies, announced in June that it will recall four of its cancer drugs and other medications both in the United States and from around the world - the fourth month in a row the company has had to warn the healthcare industry of issues related to its products.

In a joint release with the Food and Drug Administration, Hospira blamed the glass supplier for the injectables in recalling 19 lots of carboplatin, cytarabine, paclitaxel and methotrexate, which were shipped between September 2011 and April of this year. According to the release, vials of these drugs have been discovered with "visible particles embedded in the glass located at the neck of the vial." Glass particles in the medicine, in other words.'

Read more: Glass Particles Found in Injectable Cancer Drugs; Massive FDA Recall Issued